Trial Profile
A trial evaluating functional improvements after treatment with Sirolimus in patients with lymphangioleiomyomatosis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2016
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Lymphangioleiomyomatosis
- Focus Therapeutic Use
- 07 Jul 2016 New trial record
- 18 May 2016 Results presented at the 112th International Conference of the American Thoracic Society